Results for:(36 found)
Jul 14, 2014 11:10AM on Top StocksBy StreetAuthority

The drug industry is primed for huge growth in the next few years, and Warren Buffett is already investing in the company best positioned to take advantage.

Sep 19, 2013 10:59AM on Top StocksBy TheStreet Staff

Iclusig is not any more toxic than its competing leukemia drugs and its sales potential remains strong.

Sep 19, 2013 10:31AM on Top StocksBy Benzinga

Biotechnology, managed care and pharmaceuticals stocks have soared this year, helping some familiar and overlooked health care ETFs deliver stellar returns.

Sep 16, 2013 11:57AM on Top StocksBy MSN Money Partner

Under Armour is downgraded to 'neutral,' and Bristol-Myers is upgraded to 'overweight.'

Jul 31, 2013 10:55AM on Top StocksBy TheStreet Staff

The company must navigate several challenges in order for its leukemia drug Iclusig to become a blockbuster.

Jun 14, 2013 1:45PM on Top StocksBy StreetAuthority

The regulator has created an accelerated path to market for the most promising drugs -- and these health giants stand to gain the most.

Tags: MRKNVSPFE
Jun 14, 2013 12:56PM on Top StocksBy MoneyShow.com

Sometimes a more focused approach can be more advantageous.

Jun 11, 2013 2:19PM on Top StocksBy MSN Money Partner

Stocks are lower, but well off their earlier lows after the Bank of Japan held off from implementing any additional stimulus measures.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More